Ascentage Pharma Group International (AAPG) Receivables - Other (2023 - 2025)

Ascentage Pharma Group International's Receivables - Other history runs 3 years deep, the most recent figure standing at $205144.2 for Q4 2025.

• In Q4 2025, Receivables - Other fell 75.99% year-over-year to $205144.2; the TTM figure through Dec 2025 stood at $205144.2 (down 75.99% YoY), while the FY2025 annual figure was $208000.0, down 75.27% from the prior year.
• Receivables - Other for Q4 2025 stood at $205144.2, down from $854366.9 in the prior quarter.
• The five-year high for Receivables - Other was $921795.6 in Q4 2023, with the low at $205144.2 in Q4 2025.
• The 3-year median for Receivables - Other is $854366.9 (2024), against an average of $660435.6.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other decreased 7.31% in 2024, then plunged 75.99% in 2025.
• Ascentage Pharma Group International's Receivables - Other stood at $921795.6 in 2023, then dropped by 7.31% to $854366.9 in 2024, then tumbled by 75.99% to $205144.2 in 2025.
• Business Quant data shows AAPG's Receivables - Other at $205144.2 in Q4 2025, $854366.9 in Q4 2024, and $921795.6 in Q4 2023.